Navigation Links
Scientists hope to end sleeping sickness by making parasite that causes it self-destruct
Date:1/15/2010

tendency to bite its victims around the lips, in South and Central America. The parasite that causes Chagas is the world's leading cause of heart disease, and the life expectancy for patients with chronic symptoms decreases by an average of nine years.

Leishmaniasis, a disease transferred by the biting female sandfly, is prevalent in four continents and comes in four varieties, all of which either disfigure or kill its hosts. One causes skin ulcers; another causes chronic lesions resembling leprosy; the third destroys the mucus membranes in the nose, mouth and throat; the fourth causes high fever, organ swelling and, if left untreated, has a fatality rate as high as 100 percent within two years.

Screening for trypanosomal diseases is challenging, because they most often affect people in remote locations with few or no medical resources, and existing treatments lack specificity and can cause severe side effects.

Lepesheva and her team sought to damage the single-celled parasite's cellular membrane, knowing that if they could weaken that barrier, the regulation of the intercellular environment would be disrupted, and the parasite would die.

"It has been known for some time that T. brucei, the parasite that causes sleeping sickness, consumes cholesterol in its human host's blood to shore up the cellular membrane, and researchers presumed there was no getting around that," Lepesheva said. "But we suspected the parasite, like plants and animals, still might need to make its own sterols for growth and development -- functional sterols that could be targeted and inhibited."

The team chose to attack the parasite's enzyme known as 14DM, which is short for sterol 14α-demethylase. They picked 14DM because it has a counterpart in fungi, which cause athlete's foot and ringworm, and such fungal infections are commonly treated with drugs that prevent 14DM from making ergosterol, a sterol required for membrane synthesis.


'/>"/>
Contact: Angela Hopp
ahopp@asbmb.org
301-634-7389
American Society for Biochemistry and Molecular Biology
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. CSHL scientists use next-gen sequencing to rapidly discover genetic cause of devastating disorder
2. UW-Madison scientists create super-strong collagen
3. Scientists find amazing new pondlife on nature reserve
4. New spider species discovered by University of Haifa scientists
5. Eminent group of scientists call for moratorium on issuance of mountaintop mining permits
6. CSHL scientists uncover role of protein critical for activating DNA replication
7. Scientists breakthrough in production of biofuels
8. Scientists create early-warning system to defend rare Jersey cows from continental disease
9. New discovery by Harvard scientists aims to correct cellular defects leading to diabetes
10. Scripps Florida scientists show lifeless prions capable of evolutionary change and adaptation
11. Tarantula venom-based MD therapy to be advanced by UB scientists biotech company
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists hope to end sleeping sickness by making parasite that causes it self-destruct
(Date:4/2/2015)... , April 2, 2015 ... touch fingerprint sensor FPC1025 from the distributor World Peace ... commence during Q2 2015 although the major part of ... sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of ...
(Date:3/30/2015)... and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has announced ... in Automotive Sector 2014-2018" report to their offering. ... market in Automotive Sector to grow at a CAGR ... recognition is the ability of a device to identify ... recognition technology can be 2D-based or 3D-based. It uses ...
(Date:3/24/2015)... GARDENS, Fla. , March 24, 2015 /PRNewswire/ ... identity management solutions, today announced that its U.are.U ... clothing accessory retailer Goorin Bros . to ... Crossmatch biometrics-based solution secures access to the POS ... the increased risk of data breaches. ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... of autism spectrum disorders (ASD) is impairments in ... face difficulty understanding, interacting and relating with others. ... receive more intensive therapy to combat these impairments, ... "It,s important for children with ...
... Precourt Institute for Energy (PIE) and TomKat Center for ... more than $2.2 million for promising new research in ... is to help jumpstart new projects with the potential ... Lynn Orr, professor of energy resources engineering. "These ...
... a key regulator that controls the speed of development in ... this regulator, animals sped up their rate of development and ... of A research team, led by molecular geneticist Kirst King-Jones, ... DHR4: The protein acted as a sentinel to either allow ...
Cached Biology News:Children with autism benefit from early, intensive therapy 2Stanford Precourt Institute and TomKat Center award energy research grants 2Stanford Precourt Institute and TomKat Center award energy research grants 3Stanford Precourt Institute and TomKat Center award energy research grants 4Stanford Precourt Institute and TomKat Center award energy research grants 5
(Date:5/5/2015)... , May 5, 2015 ImmunoCellular ... Andrew Gengos , President and Chief Executive ... 7, 2015. DATE:  Thursday, May 7, 2015     ... http://VirtualInvestorConferences.com > click the red "register/ ... a live, interactive online event where investors are ...
(Date:5/5/2015)... and WASHINGTON, D.C., USA (PRWEB) May 05, 2015 ... U.S. export regulations covering a wide range of key ... say are hampering global competitiveness of U.S. industry. To ... a webinar on 12 May on the ... which governs the commodities covered by International Traffic in ...
(Date:5/5/2015)... 05, 2015 Research and Markets ... the "Clinical Laboratory, Molecular Diagnostics and Genomic ... 2019 - Global Version" report to their ... the area of molecular diagnostics and pharmacogenics hold ... world market that is moving out of the ...
(Date:5/5/2015)... , May 5, 2015 CytomX, a biotechnology ... today announced that Sean McCarthy , D. Phil., ... Antibody Day in New York ... McCarthy will present an overview of CytomX,s Probody pipeline, ... conjugate programs. About CytomX Therapeutics CytomX ...
Breaking Biology Technology:ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2
... As adjunctive therapy Keppra XR(TM) offers significant partial onset ... ... heritage, ATLANTA, Sept. 15 press release, regulated information:,UCB ... has,approved Keppra XR(TM) (levetiracetam extended-release tablets) for use as,an add-on ...
... Diagnostics, Inc. today,announced the appointment of Johan Skog, ... Dr. Skog will oversee the research program that,underlies ... can,identify cancer-specific genetic mutations., Dr. Skog is ... technology that has been licensed exclusively to the ...
... milestone payments and promotional investment totaling up to ... $385 million ... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today that it ... prolonged release,tablets) in Europe and other countries to the Menarini ...
Cached Biology Technology:Video: Keppra XR(TM) Approved in the U.S. 2Video: Keppra XR(TM) Approved in the U.S. 3Video: Keppra XR(TM) Approved in the U.S. 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 2CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 3CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 5